new glp 1 med GLP-1 medication changes may support long-term weight management Which GLP-1 medication is most

CJC-1295 is a growth hormone releasing hormone (GHRH) analog with an extended half-life of 5.8 to 8.1 days

An open-label uncontrolled trial including 27 patients with T2D and NAFLD treated with liraglutide 0.9 mg/day for 24 weeks showed a trend toward increases in liver-to-spleen attenuation ratio assessed by CT scan and, more importantly, a significant improvement in histological inflammatory scores in 10 subjects undergoing liver biopsies after a prolonged treatment of 96 weeks (64)

doi: 10.1016/j.immuni.2016.02.016 35 BoutilierAJElsawaSF

Soft, cold, and low-smell options are easiest of all

Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis

Conclusion The present review encompassed a roundup of studies on the anti-cancer effects of several anti-diabetic compounds in TC